Subcutaneous injection of a murine pancreatic ductal adenocarcinoma cell line (KPC) with mouse Gli2/Gli3-knock-out (KO) fibroblasts in mice led to a reduction in tumor growth, decreased the recruitment of MDSCs and increased NK cells (Figure 2). The gene discussed is GLI3; the disease is pancreatic ductal adenocarcinoma.